| Xanthine scaffold: scope and potential in drug development N Singh, AK Shreshtha, MS Thakur, S Patra Heliyon 4 (10), 2018 | 99 | 2018 |
| Phosphodiesterase 9: insights from protein structure and role in therapeutics N Singh, S Patra Life sciences 106 (1-2), 1-11, 2014 | 27 | 2014 |
| Development of xanthine based inhibitors targeting phosphodiesterase 9A N Singh, P Saravanan, MS Thakur, S Patra Letters in Drug Design & Discovery 14 (10), 1122-1137, 2017 | 9 | 2017 |
| Identification of xanthine derivatives as inhibitors of phosphodiesterase 9A through in silico and biological Studies N Singh, S Patra, S Patra Combinatorial Chemistry & High Throughput Screening 21 (7), 476-486, 2018 | 5 | 2018 |
| A comprehensive review on structural and therapeutical insight of Cerebroside sulfotransferase (CST)- an important target for development of substrate reduction therapy against … N Singh, AK Singh International Journal of Biological Macromolecules, 2023 | 1 | 2023 |
| Diversifying the xanthine scaffold for potential phosphodiesterase 9A inhibitors: synthesis and validation N Singh, AH Malik, PK Iyer, S Patra Medicinal Chemistry Research 30, 1199-1219, 2021 | 1 | 2021 |
| In Silico Structural modeling and binding site analysis of Cerebroside Sulfotransferase (CST)– a therapeutic target for developing substrate reduction therapy for Metachromatic … N Singh, AK Singh ACS Omega, 2024 | | 2024 |
| Xanthine as a scaffold for synthesis of novel compounds. N Singh, AH Malik, PK Iyer, S Patra IN Patent, Intellectual Property India, 2021 | | 2021 |
| Xanthine based inhibitors for therapeutics targeting phosphodiesterase 9A N Singh IIT Guwahati, 2016 | | 2016 |
| Algal phycobiliproteins N Singh, AK Singh RSC (under preparation), 0 | | |
